Janus Henderson Group’s Relmada Therapeutics RLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,937
Closed -$220K 2495
2022
Q3
$220K Buy
+5,937
New +$220K ﹤0.01% 2360